Literature DB >> 17031540

Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.

Aurélien Monge1, Alban Arrault, Christophe Marot, Luc Morin-Allory.   

Abstract

The data for 3.8 million compounds from structural databases of 32 providers were gathered and stored in a single chemical database. Duplicates are removed using the IUPAC International Chemical Identifier. After this, 2.6 million compounds remain. Each database and the final one were studied in term of uniqueness, diversity, frameworks, 'drug-like' and 'lead-like' properties. This study also shows that there are more than 87 000 frameworks in the database. It contains 2.1 million 'drug-like' molecules among which, more than one million are 'lead-like'. This study has been carried out using 'ScreeningAssistant', a software dedicated to chemical databases management and screening sets generation. Compounds are stored in a MySQL database and all the operations on this database are carried out by Java code. The druglikeness and leadlikeness are estimated with 'in-house' scores using functions to estimate convenience to properties; unicity using the InChI code and diversity using molecular frameworks and fingerprints. The software has been conceived in order to facilitate the update of the database. 'ScreeningAssistant' is freely available under the GPL license.

Mesh:

Substances:

Year:  2006        PMID: 17031540     DOI: 10.1007/s11030-006-9033-5

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  34 in total

1.  Improving the odds in discriminating "drug-like" from "non drug-like" compounds.

Authors:  T M Frimurer; R Bywater; L Naerum; L N Lauritsen; S Brunak
Journal:  J Chem Inf Comput Sci       Date:  2000 Nov-Dec

2.  Drug-like index: a new approach to measure drug-like compounds and their diversity.

Authors:  J Xu; J Stevenson
Journal:  J Chem Inf Comput Sci       Date:  2000 Sep-Oct

Review 3.  An overview of the diversity represented in commercially-available databases.

Authors:  Mary P Bradley
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

Review 4.  Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.

Authors:  Andrew M Davis; Simon J Teague; Gerard J Kleywegt
Journal:  Angew Chem Int Ed Engl       Date:  2003-06-23       Impact factor: 15.336

Review 5.  Selection criteria for drug-like compounds.

Authors:  Ingo Muegge
Journal:  Med Res Rev       Date:  2003-05       Impact factor: 12.944

Review 6.  Molecular properties that influence oral drug-like behavior.

Authors:  Michael S Lajiness; Michal Vieth; Jon Erickson
Journal:  Curr Opin Drug Discov Devel       Date:  2004-07

7.  Enhancement of the chemical semantic web through the use of InChI identifiers.

Authors:  Simon J Coles; Nick E Day; Peter Murray-Rust; Henry S Rzepa; Yong Zhang
Journal:  Org Biomol Chem       Date:  2005-04-18       Impact factor: 3.876

8.  A global resource for computational chemistry.

Authors:  Peter Murray-Rust; Henry S Rzepa; James J P Stewart; Yong Zhang
Journal:  J Mol Model       Date:  2005-07-21       Impact factor: 1.810

9.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

Authors:  A Ajay; W P Walters; M A Murcko
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

10.  Lead- and drug-like compounds: the rule-of-five revolution.

Authors:  Christopher A Lipinski
Journal:  Drug Discov Today Technol       Date:  2004-12
View more
  16 in total

1.  Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment.

Authors:  Alexandre Beautrait; Vincent Leroux; Matthieu Chavent; Léo Ghemtio; Marie-Dominique Devignes; Malika Smaïl-Tabbone; Wensheng Cai; Xuegang Shao; Gilles Moreau; Peter Bladon; Jianhua Yao; Bernard Maigret
Journal:  J Mol Model       Date:  2008-01-03       Impact factor: 1.810

2.  Many InChIs and quite some feat.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2015-06-17       Impact factor: 3.686

3.  Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.

Authors:  Emilie Pihan; Roberto F Delgadillo; Michelle L Tonkin; Martine Pugnière; Maryse Lebrun; Martin J Boulanger; Dominique Douguet
Journal:  J Comput Aided Mol Des       Date:  2015-03-31       Impact factor: 3.686

Review 4.  Rational methods for the selection of diverse screening compounds.

Authors:  David J Huggins; Ashok R Venkitaraman; David R Spring
Journal:  ACS Chem Biol       Date:  2011-02-15       Impact factor: 5.100

5.  Structure-based virtual screening of hypothetical inhibitors of the enzyme longiborneol synthase-a potential target to reduce Fusarium head blight disease.

Authors:  E Bresso; V Leroux; M Urban; K E Hammond-Kosack; B Maigret; N F Martins
Journal:  J Mol Model       Date:  2016-06-21       Impact factor: 1.810

6.  A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands.

Authors:  Jingxian Zhang; Bucong Han; Xiaona Wei; Chunyan Tan; Yuzong Chen; Yuyang Jiang
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

7.  ChemMine tools: an online service for analyzing and clustering small molecules.

Authors:  Tyler W H Backman; Yiqun Cao; Thomas Girke
Journal:  Nucleic Acids Res       Date:  2011-05-16       Impact factor: 16.971

Review 8.  QSPR studies on aqueous solubilities of drug-like compounds.

Authors:  Pablo R Duchowicz; Eduardo A Castro
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

9.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

10.  Mining collections of compounds with Screening Assistant 2.

Authors:  Vincent Le Guilloux; Alban Arrault; Lionel Colliandre; Stéphane Bourg; Philippe Vayer; Luc Morin-Allory
Journal:  J Cheminform       Date:  2012-08-31       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.